Our current finding that IL-6 concentrations relate to those of resistin and that IL-6 and resistin concentrations are associated with endothelial activation independent of one another supports our previous study [37] as well as the potential use of both of these biomarkers in cardiovascular risk stratification in RA. Here, IL6 is linked to rheumatoid arthritis.